U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07891468) titled 'Phase 1 Study of huCART19-IL18-CD428z Cells for the Treatment of Patients With HIV With CD19+ Cancers' on Oct. 16.
Brief Summary: This research study is being conducted to evaluate an experimental drug called huCART19-IL18-CD428z cells in patients living with HIV who have been diagnosed with Non-Hodgkin Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Acute Lymphoblastic Leukemia (ALL), and Richter's Transformation (RT).
Study Start Date: Jan., 2027
Study Type: INTERVENTIONAL
Condition:
Non-Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
Acute Lymphoblastic Leukemia
Richter's Transformation
Intervention:
BIOLOGICAL: huCART19-...